Mueller, Elizabeth R.
Weiss, Jeffrey P.
Bosch, J. L. H. Ruud
Chughtai, Bilal
Rosenberg, Matt T.
Bacci, Elizabeth D.
Simeone, Jason C.
Andersson, Fredrik L.
Juul, Kristian
Coyne, Karin S.
Chapple, Christopher R.
Article History
Received: 14 September 2022
Accepted: 22 November 2022
First Online: 28 January 2023
Declarations
:
: Elizabeth R. Mueller is a consultant to Ferring Pharmaceuticals, Inc., Butler Snow Pharmaceutical, Ethicon (legal consultation), and UpToDate (author royalties). Jeffrey P. Weiss is a consultant to Ferring Pharmaceuticals, Inc., and the Institute for Bladder and Prostate Research. J.L.H. Ruud Bosch is a consultant to Ferring Pharmaceuticals, Inc. Bilal Chughtai is a consultant to Ferring Pharmaceuticals, Inc., Boston Scientific, Olympus, Medi-Tate, Medeonbio, and Urovant. Matt T. Rosenberg is a consultant to Ferring Pharmaceuticals, Inc., Astellas, Urovant, and Sunovion. Karin S. Coyne and Elizabeth D. Bacci are employed by Evidera, and Jason Simeone was employed at Evidera while the study was being conducted, receiving funding from Ferring Pharmaceuticals, Inc. Fredrik L. Andersson and Kristian Juul are employed by Ferring Pharmaceuticals. Christopher R. Chapple reports disclosures as follows: speaker for Allergan; author for Astellas Pharma; author and consultant to Ferring Pharmaceuticals, Inc., and consultant to Proverum, Symimetic, and Urovant Sciences.